We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Fresenius SE and Company KGaA (PK) | USOTC:FSNUY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.112 | -1.48% | 7.4405 | 7.32 | 7.63 | 7.53 | 7.4405 | 7.53 | 44,836 | 21:23:30 |
From Jun 2019 to Jun 2024
By Cecilia Butini
Fresenius SE & Co. said Monday that its hospital-operating division Fresenius Helios has acquired fertility services provider Eugin Group at a valuation of 430 million euros ($527.1 million).
The German health-care company said the acquisition of the group--which consists of Luarmia SL and NMC Eugin US Corporation--is "expected to be highly accretive to group net income already in 2021". The company said it doesn't expect any meaningful intergration expenses as a result of the acquisition.
"Eugin Group will form a new and separate Fresenius Helios business and reporting unit alongside Helios Germany and Helios Spain," Fresenius said.
It said the purchase price will be financed from existing cash and credit lines.
The transaction is expected to close in the first half of 2021, pending regulatory approval.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
December 21, 2020 03:50 ET (08:50 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Fresenius SE and Company... (PK) Chart |
1 Month Fresenius SE and Company... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
